Predisposed to doze: Promethazine, CYP2D6 poor metabolizer

Erica D. Wittwer, Juraj Sprung, Wayne T. Nicholson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This case discusses a drug-gene interaction. Promethazine is a cytochrome P450 (CYP) 2D6 substrate. Patients who are CYP2D6 poor metabolizers exhibit greater sedation for a given promethazine dose.

Original languageEnglish (US)
Title of host publicationA Case Approach to Perioperative Drug-Drug Interactions
PublisherSpringer New York
Pages401-403
Number of pages3
ISBN (Print)9781461474951, 9781461474944
DOIs
StatePublished - Sep 15 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Predisposed to doze: Promethazine, CYP2D6 poor metabolizer'. Together they form a unique fingerprint.

  • Cite this

    Wittwer, E. D., Sprung, J., & Nicholson, W. T. (2015). Predisposed to doze: Promethazine, CYP2D6 poor metabolizer. In A Case Approach to Perioperative Drug-Drug Interactions (pp. 401-403). Springer New York. https://doi.org/10.1007/978-1-4614-7495-1_86